Imatinib Mesylate
Get a Quick Quote Now
Select Packaging
For more information call 
(914) 654-6800or email 
INFO@PARCHEM.COM
(914) 654-6800
INFO@PARCHEM.COM
For more informationemailINFO@PARCHEM.COM
email
INFO@PARCHEM.COM
Product Description
Product
Imatinib Mesylate
CAS
220127-57-1
Formula
C29H31N7O.CH4SO3
Synonym
Imatinib mesylate, 220127-57-1, Gleevec, Glivec, Imatinib mesilate, imatinib methanesulfonate, sti-571, Imatinib Mesylate (STI571), Imatinib (mesylate), Imatinib accord, Imatinib medac, CGP-57148B, imatinib monomesylate, NSC-716051, STI 571, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate, QTI-571, ST-1571 Mesylate, CGP 57148B, Imatinib (as mesilate), 220127-57-1 (mesylate), Imatinib methane sulfonate, Imatinib mesylate [USAN], QTI571, N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate, DTXSID9040502, CHEBI:31690, 8A1O1M485B, MFCD04307699, Imatinib mesilate (JAN), Imatinib mesylate (USAN), 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate, Imatinib Methansulfonate, N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate, IMATINIB MESILATE [JAN], DTXCID7020502, Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1), CAS-220127-57-1, CGP-57148, NCGC00159456-02, Gleevec (Imatinib mesylate), Genfatinib, Gleevac, Shantinib, ImatinibMesylate, Imatinib, methanesulfonate salt, HSDB 7142, Gleevec (TN), Imatinib(free base), Glivec (TN), SCHEMBL8217, Imatinib monomethanesulfonate, CHEMBL1642, Benzamide,monomethanesulfonate, Imatinib methanesulfonate salt, MLS001401456, UNII-8A1O1M485B, C29H31N7O.CH4O3S, IMATINIB MESYLATE [HSDB], EX-A954, IMATINIB MESYLATE [VANDF], IMATINIB MESILATE [MART.], BCPP000204, GGP-57148B, HMS2052B09, HMS2233D16, HMS3265E01, HMS3265E02, HMS3265F01, HMS3265F02, HMS3372O12, HMS3394B09, HMS3654C07, IMATINIB MESILATE [WHO-DD], ACT05102, BCP01255, Tox21_111684, AC-525, HB1943, NSC716051, s1026, IMATINIB METHANESULFONATE [MI], AKOS015852497, Tox21_111684_1, BCP9000776, CCG-101175, IMATINIB MESYLATE
Typical Product Specifications
Molecular weight
589.71
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Imatinib Mesylate is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
Imatinib Mesylate
For more information call (914) 654-6800or email INFO@PARCHEM.COM
(914) 654-6800
INFO@PARCHEM.COM
For more informationemailINFO@PARCHEM.COM
email
INFO@PARCHEM.COM
Product Description
Product
Imatinib Mesylate
CAS
220127-57-1
Formula
C29H31N7O.CH4SO3
Synonym
Imatinib mesylate, 220127-57-1, Gleevec, Glivec, Imatinib mesilate, imatinib methanesulfonate, sti-571, Imatinib Mesylate (STI571), Imatinib (mesylate), Imatinib accord, Imatinib medac, CGP-57148B, imatinib monomesylate, NSC-716051, STI 571, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate, QTI-571, ST-1571 Mesylate, CGP 57148B, Imatinib (as mesilate), 220127-57-1 (mesylate), Imatinib methane sulfonate, Imatinib mesylate [USAN], QTI571, N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate, DTXSID9040502, CHEBI:31690, 8A1O1M485B, MFCD04307699, Imatinib mesilate (JAN), Imatinib mesylate (USAN), 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate, Imatinib Methansulfonate, N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate, IMATINIB MESILATE [JAN], DTXCID7020502, Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1), CAS-220127-57-1, CGP-57148, NCGC00159456-02, Gleevec (Imatinib mesylate), Genfatinib, Gleevac, Shantinib, ImatinibMesylate, Imatinib, methanesulfonate salt, HSDB 7142, Gleevec (TN), Imatinib(free base), Glivec (TN), SCHEMBL8217, Imatinib monomethanesulfonate, CHEMBL1642, Benzamide,monomethanesulfonate, Imatinib methanesulfonate salt, MLS001401456, UNII-8A1O1M485B, C29H31N7O.CH4O3S, IMATINIB MESYLATE [HSDB], EX-A954, IMATINIB MESYLATE [VANDF], IMATINIB MESILATE [MART.], BCPP000204, GGP-57148B, HMS2052B09, HMS2233D16, HMS3265E01, HMS3265E02, HMS3265F01, HMS3265F02, HMS3372O12, HMS3394B09, HMS3654C07, IMATINIB MESILATE [WHO-DD], ACT05102, BCP01255, Tox21_111684, AC-525, HB1943, NSC716051, s1026, IMATINIB METHANESULFONATE [MI], AKOS015852497, Tox21_111684_1, BCP9000776, CCG-101175, IMATINIB MESYLATE
Typical Product Specifications
Molecular weight
589.71
Assay/Purity
Typically NLT 98%
Chemical Structure
Notes
Imatinib Mesylate is classified as an: Active Pharmaceutical Ingredient (API) / Pharmaceutical Intermediate
Class
Industry
